Fair Value Measurement (Narrative) (Details) |
Mar. 31, 2026
USD ($)
subsidiary
|
Dec. 31, 2025
USD ($)
|
|---|---|---|
| Credit Derivatives [Line Items] | ||
| Number of proassurance's insurance subsidiaries | subsidiary | 2 | |
| Fair value of funded deferred compensation assets | $ 21,700,000 | $ 23,200,000 |
| Fair Value | ||
| Credit Derivatives [Line Items] | ||
| Deferred compensation liabilities | 20,900,000 | 22,500,000 |
| Fair Value, Nonrecurring | ||
| Credit Derivatives [Line Items] | ||
| Fair value, net asset (liability) | $ 0 | $ 0 |
| X | ||||||||||
- Definition Number of Insurance Subsidiaries No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date. No definition available.
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of assets held under deferred compensation agreements. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Fair value of asset after deduction of liability. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|